Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

CWBR

CohBar (CWBR)

CohBar Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CWBR
일자시간출처헤드라인심볼기업
2023/11/2808:05Business WireCohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)NASDAQ:CWBRCohBar Inc
2023/11/2807:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CWBRCohBar Inc
2023/11/1323:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CWBRCohBar Inc
2023/11/0122:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CWBRCohBar Inc
2023/10/2522:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:CWBRCohBar Inc
2023/10/2522:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CWBRCohBar Inc
2023/10/0705:13Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:CWBRCohBar Inc
2023/10/0705:11Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CWBRCohBar Inc
2023/10/0422:14Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:CWBRCohBar Inc
2023/10/0422:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CWBRCohBar Inc
2023/09/1313:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CWBRCohBar Inc
2023/09/1305:47Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CWBRCohBar Inc
2023/09/1302:44Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:CWBRCohBar Inc
2023/08/1505:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CWBRCohBar Inc
2023/08/1505:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CWBRCohBar Inc
2023/08/1505:01GlobeNewswire Inc.CohBar Reports Second Quarter 2023 Financial ResultsNASDAQ:CWBRCohBar Inc
2023/08/1106:30Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:CWBRCohBar Inc
2023/06/0521:05GlobeNewswire Inc.Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)NASDAQ:CWBRCohBar Inc
2023/06/0105:51Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CWBRCohBar Inc
2023/05/3021:05GlobeNewswire Inc.Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CWBRCohBar Inc
2023/05/2320:56Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CWBRCohBar Inc
2023/05/2320:30GlobeNewswire Inc.CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer ImmunotherapyNASDAQ:CWBRCohBar Inc
2023/05/1521:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CWBRCohBar Inc
2023/04/2822:01Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CWBRCohBar Inc
2023/03/1006:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CWBRCohBar Inc
2023/02/0823:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CWBRCohBar Inc
2023/02/0823:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CWBRCohBar Inc
2022/12/0723:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CWBRCohBar Inc
2022/11/1722:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CWBRCohBar Inc
2022/11/0906:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CWBRCohBar Inc
 검색 관련기사 보기:NASDAQ:CWBR